Guideline-Based Follow-Up Outcomes in Patients With Gastrointestinal Stromal Tumor With Low Risk of Recurrence: A Report From the Italian Sarcoma Group.

ABSTRACT:

Importance

Gastrointestinal stromal tumor (GIST) follow-up is recommended by international guidelines, but data on the role of follow-up in patients with low relapse risk are missing. For these patients, the potential benefit of anticipating recurrence detection should be weighed against psychological burden and radiologic examination loads in terms of costs and radiation exposure.

Objective

To evaluate the outcomes of guideline-based follow-up in low-risk GIST.

Design, setting, and participants

This multi-institutional retrospective cohort study involving Italian Sarcoma Group reference institutions evaluated patients with GIST who underwent surgery between January 2001 and June 2019. Median follow-up time was 69.2 months. Data analysis was performed from December 15

SUBMITTER: D'Ambrosio L 

PROVIDER: S-EPMC10628737 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature